Dr. Fatima Al Kaabi has been appointed as the Director General of the Emirates Drug Establishment. Serving concurrently as the Executive Director of the Abu Dhabi Bone Marrow Transplant Program (AD-BMT©) at Abu Dhabi Stem Cells Center since 2019, Dr. Al Kaabi is a leading figure in UAE’s healthcare sector. She is also the Vice-Chair of the UAE National Multiple Sclerosis Society Board of Trustees and the Chairperson of UAE BIOTECH Research Center. Her academic journey includes earning an MPH from Johns Hopkins University in 2001 and an MSc in Cancer from University College London in 2012. Furthermore, she completed her fellowship in hematology in the Royal Free Hospital in the United Kingdom. Previously, Dr. Al Kaabi held multiple leadership positions including the Executive Director of Emirates Genome and Health Affairs at Abu Dhabi Executive Office (ADEO); Head of Adult Hematology/Oncology and Deputy Chief Medical Officer at Sheikh Khalifa Medical City (SKMC) in Abu Dhabi. In her current roles, Dr. Al Kaabi continues to make significant contributions to the healthcare sector, leveraging her experience and dedication to drive positive change and advancements in the field.
Dr. Amin Al Ameeri is a distinguished healthcare leader with a proven track record of innovation and excellence. As the Assistant Undersecretary at the Ministry of Health and Prevention in the United Arab Emirates, H.E. oversees critical functions such as setting standards, drug administration, licensing, inspection, and organ donation and transplantation. With a Ph.D. in Blood Transfusion Medicine from the University of Aberdeen in Scotland, Dr. Al Ameeri has made significant contributions to the field. His expertise and dedication have been recognized with numerous awards, both locally and internationally. A visionary leader, Dr. Al Ameeri is committed to improving healthcare quality and accessibility in the UAE. His strategic guidance and innovative approaches have played a pivotal role in advancing the nation's healthcare system.
Dan Vahdat is a technology entrepreneur and the Founder and CEO of Huma, a global healthcare AI company building national-scale digital health and research infrastructure. His work centres on regulated AI, real-world data platforms, and large public-private partnerships that modernise healthcare systems in collaboration with governments, health systems, and leading life sciences organisations. He began his PhD at Johns Hopkins University, focusing on the intersection of deep technology, medicine, and large-scale systems, before leaving the program to found Huma. Vahdat has led major digital health transformation programs across Europe, the Middle East, and North America, and is recognised internationally for bridging technology, policy, and healthcare delivery. His work has been featured at global policy and innovation forums and associated with prestigious industry recognition, including the Prix Galien (often referred to as the “Nobel Prize of biopharmaceutical research”).
Dr Madhu Sasidhar is the President & CEO of Apollo Hospitals. Dr Sasidhar is a practising physician with US board certifications in internal medicine, pulmonary, and critical care medicine. He completed his medical education at JIPMER, Pondicherry. Following a residency in Internal Medicine at St Luke’s Roosevelt Hospital in New York City, he completed fellowships in Pulmonary and Critical Care Medicine at Yale University, New Haven, USA. He received his Global Executive Master's in Business Administration from INSEAD, Fontainebleau, France. Dr Sasidhar served as President of Cleveland Clinic Tradition Hospital. Before that, he was the Chief Medical Officer at Cleveland Clinic Abu Dhabi and Enterprise Section Head for Respiratory Care for the Cleveland Clinic Health System. Dr Sasidhar has published numerous book chapters, journal and peer-reviewed articles, abstracts, and presentations and has been invited to speak on various topics at many industry events. He holds a patent through Cleveland Clinic Innovations for a technology he invented that was subsequently commercialised. Dr Sasidhar is also a self-taught computer programmer with expertise in big data platforms.
Majid Kaddoumi is Senior Vice President and President, Europe, Middle East, Africa and Asia Pacific (EurAsia). The region comprises of the Enterprise Accounts & Services for Western Europe, Japan, Australia and New Zealand and the region-led markets of Central and Eastern Europe, Middle East, Africa, Russia and Asia Pacific. Majid serves as a member of Medtronic’s Executive Committee. With over 25 years of experience in operations, services and medical technology, Majid has vast experience in both commercial and operational leadership. Prior to joining Medtronic, Majid was General Manager for General Electric Healthcare (GEHC) for Saudi Arabia. During his tenure at GEHC, he won several President Awards for his achievements and business innovations. Before joining GEHC, Majid was General Manager of a leading distribution and turnkey solutions company based in Saudi Arabia, serving the Middle East. Majid successfully built and established two companies before transitioning into the corporate world.
Dr. Haidar Alyousuf is one of the most prominent figures in the UAE healthcare industry and the CEO of iO Health, a UAE-based Cognitive AI company whose platforms are today impacting over 32 million lives across the GCC and beyond. In 2013, Dr. Alyousuf led the design and successful implementation of the health insurance system of the Emirate of Dubai and the mandatory health insurance law for Dubai, law no 11 for 2013, signed by HH Shiekh Mohammed bin Rashid Al Maktoum Vice president of the UAE, Ruler of Dubai, achieving total healthcare coverage for the population in three years and regulating one of the most recognized health systems in region. Before leading iO Health, Dr. Alyousuf built AlFuttaim Health from inception into a 1,000-person integrated healthcare enterprise with around 40 operational business units, and the first internationally accredited primary care group in the UAE.
Since August 2019, Dr Mate has served as Chief Executive Officer of Schön Klinik SE, one of Germany’s top five private hospital groups with a leading position in mental health and a strong footprint in somatic medicine, operating 16 hospitals and 12 outpatient centres in Germany and the UK with around €1bn annual revenue and 12,000 employees. Prior to this, he was Managing Director New Business Areas at Helios Group (09/2018–07/2019), where he developed new segments such as occupational medicine, prevention, and telemedicine/virtual clinic and built international cross-selling opportunities within Helios and Fresenius. From 2010 to 2018, he held successive general management roles at Helios, including Regional Managing Director (Central Region) and Managing Director of Helios Hospital Berlin-Buch, driving multi-year budget overperformance and significant profitability improvements, after earlier leadership positions at Trinity Hospital Cologne combining medical responsibility with finance/controlling, complemented by project work in hospital management in Basel and clinical training at University Hospital Basel across traumatology, general surgery, and emergency medicine.
Peter Fedichev is the co-founder and CEO of Gero, a biotech company pioneering AI-driven therapeutics to extend human healthspan and combat age-related diseases. He is one of the few global experts combining two rare qualities — a scientist with internationally recognized fundamental discoveries and a successful entrepreneur leading a company that is reshaping the longevity industry. Peter is also a Professor at the National University of Singapore (ranked among the world’s Top 10 universities). His rare public appearances are considered key events that help shape the scientific and business agenda of the longevity field.
Mohamed is the VP General Manager of Amgen in the Middle East & Africa (MEA), with over two
decades of experience in the Pharmaceutical and Biotech fields in various leadership roles in
strategic planning, business development and general management across Europe, Middle East &
Africa.
Additionally, he serves as the chairman of the pharmaceutical industry association in MEA
(PHARMEA). The association contributes significantly to the industry-government dialogue and
policy making in the region enhancing patient access to innovative medicines. Mohamed's
dedication to healthcare is motivated by a commitment to support patients during their most
challenging times.
He is a pharmacist, holds an MBA from Bradford University- UK, and a Six Sigma Black Belt. He is
also a member of the board of several companies in healthcare and technology startup sectors.
Anna Titkova, MD, PhD, Professor Assoc., MBA, International Operations Director Pratia, Country Head Ukraine Anna graduated from Kharkiv National Medical University and works as as Assoc. Professor and researcher at Dnipro Institute of Medicine and Public Health. She has a PhD, Master of Medical and Educational Sciences, MBA, completed an internship at Harvard and Yale Universities, and is a qualified international lecturer and senior researcher. In March 2020, Anna opened the Pratia Ukraine LLC and the first SMO clinical research site, Pratia Clinic Ukraine LLC, part of the international site network Pratia under the umbrella of the NEUCA group. Her company works with 10 medical institutions in 3 Ukrainian regions in the clinical trials field. From 2022 she combines her local activites with international operations within the Pratia network of clinical research sites in 8 European countries.
Hugo Hagen is Vice President and Head of Global Health Unit at Bayer. He plays a pivotal role in advancing Bayer's mission through focusing on expanding access to essential medicines and empowering underserved communities, particularly in over 50 low- and middle-income countries (LMICs) where Bayer has little or no presence. With extensive experience in advancing high-growth markets, Hugo has consistently championed innovation, driven social and environmental impact and prioritized cultivating key strategic collaborations. Hugo previously served as the Senior Bayer Representative (SBR) for the Middle East and serves as the Country Division Head (CDH) for Bayer’s Pharmaceuticals Division in the Middle East and North Africa. With over 12 years of experience at Bayer alone, Hugo’s role is intrinsic to supporting Bayer’s commitment of transforming healthcare solutions and driving sustainable impact in the region.
Prof. Faisal Abaalkhail is a Senior Gastroenterologist and Transplant Hepatologist at King Faisal Specialist Hospital & Research Centre - Riyadh, KSA and a Professor of Medicine at the College of Medicine at Al Faisal University. He currently serves as the President of the Saudi Society for the Study of Liver Diseases and Transplantation (SASLT) and the Governor of the American College of Physicians - Saudi Arabia Chapter.
Dr. Manish Madnani is a Specialist Gastrointestinal and Laparoscopic Surgeon and Head of Surgical Division for the Al Nahda Cluster at NMC Specialty Hospital and Clinics, Dubai. With advanced qualifications including MS (General Surgery, Gold Medalist), DNB (GI Surgery), MRCS (England), FACS (USA), and FARIS (Robotic Surgery), MSc Healthcare Leadership from University of Liverpool, he brings a wealth of clinical expertise spanning complex laparoscopic, robotic, and open GI procedures. He holds registrations with the GMC UK, DHA UAE, and NHRA Bahrain, and is a UAE Golden Visa holder. Beyond the operating theatre, Dr. Madnani leads surgical governance, quality improvement, and multidisciplinary care delivery across his cluster, and holds Lean Six Sigma Green Belt and Black Belt certifications. He is passionate about advancing surgical standards in the region and fostering a culture of clinical excellence, innovation, and patient-centric care.
Dr Bohaira Elgeyoushi has over 20 years of experience as a Consultant Gynaecologist specialising in Reproductive Medicine (IVF). She previously led the Fertility Department at East Kent University Hospitals NHS Foundation Trust, one of the UK’s largest NHS trusts, and she was the trust's leadership lead.
Dr Bohaira is a Fellow of the RCOG and CoSRH in London. She was awarded a Doctorate of Medicine from the University of Southampton on “Studies in Women's Reproductive Healthcare”. This generated widely published articles in peer-reviewed journals from the resulting research.
Her legacy lives through the three IVF clinics she established during her 12 years in Dubai, she has organised more than six international conferences, workshops, and educational events focusing on fertility and women’s health
Dr Bohaira is passionate about women’s healthcare and fertility management, emphasising a holistic, patient-centered approach and personalised fertility care. She strongly advocates education and empowerment, helping women make informed decisions about their fertility and reproductive health. Her commitment to education and excellence makes her reputation well-known as a leader in reproductive medicine.
Dr. Tamer Rizk A highly accomplished Consultant Pediatric Neurologist currently practicing at the American Center for Psychiatry and Neurology (ACPN) in Abu Dhabi, UAE. With over 20 years of international experience, his medical career spans clinical practice, academic leadership, and medical research across the USA, UK, Canada, Saudi Arabia, and Egypt. He is a major academic contributor to pediatric neurosciences, with more than 50 published scientific articles in medical journals. His primary research focuses on neuro-management modalities, movement disorders, and spasticity. He has also authored textbooks addressing epilepsy, dystonia, and spasticity, and serves on the editorial boards of multiple pediatric neurology medical journals.
When Dr. Mazin Rasool Aljabiri arrived in the United Arab Emirates in 2011, advanced interventional gastroenterology was still in its early stages. Over the past decade, he has helped transform the specialty, contributing to the UAE’s emergence as a regional leader in advanced digestive healthcare through innovation, education, and minimally invasive treatment.
A British-trained Consultant Gastroenterologist, Interventional Endoscopist, and Fellow of the Royal College of Physicians (London), Dr. Aljabiri is Head of Gastroenterology and Digestive Diseases at Mediclinic Parkview Hospital and an Honorary Clinical Assistant Professor at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). Throughout his career, he has remained committed to a single vision: bringing world-class digestive healthcare to patients in the UAE while developing sustainable centres of excellence that combine clinical expertise, education, research, and innovation.
Under his leadership, Mediclinic Parkview Hospital has evolved into one of the region’s leading centres for advanced therapeutic endoscopy and achieved international recognition as an Endoscopy Centre of Excellence. He has led the introduction of numerous advanced endoscopic procedures in the UAE, including SpyGlass™️ cholangioscopy, advanced ERCP, endoscopic bariatric therapies, and minimally invasive treatments for gastro-oesophageal reflux disease and early gastrointestinal cancers, allowing many patients to avoid major surgery and overseas referral.
Recognising the transformative potential of artificial intelligence, Dr. Aljabiri also led the implementation of AI-assisted colonoscopy within Mediclinic, contributing to one of the UAE’s first comparative studies demonstrating improved adenoma detection rates through AI-supported endoscopy. His work reflects a belief that technology should enhance, not replace, clinical judgement, enabling safer, more precise, and more personalised patient care.
Over the course of his career, Dr. Aljabiri has performed more than 70,000 diagnostic and therapeutic endoscopic procedures, including advanced ERCP, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), complex polypectomy, haemostasis, and pancreatobiliary interventions. He is widely recognised for combining technical excellence with meticulous clinical judgement and compassionate, patient-centred care.
Before relocating to the UAE, Dr. Aljabiri completed specialist gastroenterology training within the UK’s North East London Deanery, training at internationally renowned institutions including University College London Hospitals, The Royal Free Hospital, Barts and The London, and Basildon University Hospital. His academic contributions include peer-reviewed publications, international presentations, and ongoing involvement in postgraduate medical education.
Beyond clinical practice, Dr. Aljabiri has become a recognised leader in advancing gastroenterology across the Middle East. As a member of the executive leadership of the Emirates Digestive Disease Group and CEO of Emirates Digestive Disease Week (EDDW), he has helped establish one of the region’s leading educational platforms, bringing together internationally renowned faculty, cutting-edge innovation, and multidisciplinary training to elevate standards of digestive healthcare.
His contributions to medicine have been recognised through numerous national and international appointments, including his recognition as Elite Gastroenterologist of the Year 2026. However, Dr. Aljabiri believes that his greatest achievement is not the number of procedures performed or technologies introduced, but the lasting systems, teams, and future leaders he has helped build.
Looking ahead, his ambition is to position the UAE among the world’s leading destinations for advanced digestive healthcare by integrating precision medicine, artificial intelligence, minimally invasive therapies, and world-class education into everyday clinical practice. He believes that true innovation is measured not by the technologies introduced, but by the lives improved, the professionals inspired, and the healthcare systems strengthened for generations to come.
“Success in medicine is not measured by the number of procedures we perform, but by the suffering we prevent, the lives we improve, and the future we help build.” — Dr. Mazin Rasool Aljabiri
Dr. Mohammed Khusheim is a consultant in Internal and Geriatric Medicine graduated from University of Calgary in Canada. He is the Lead of the Long-Term Care Service at Care Medical and Geriatric Clinic Lead at Seha Virtual Hospital, Ministry of Health. A Johns Hopkins Masters of Public Health graduate he is also an adjunct faculty member at Alfaisal University. Dr. Khusheim has led national initiatives on dementia, falls, and aging, and has contributed to clinical policy, education, and media outreach across Saudi Arabia. He is the founder of AgelessAgenda.com, promoting geriatric public health awareness.
Dr Yasmin Giambrone is Head of Radiology at King’s College Hospital London – Dubai and a UK-trained Consultant Breast and Diagnostic Radiologist. She combines executive healthcare leadership with an active clinical practice in breast imaging and intervention, driving innovation in radiology and advancing the responsible integration of artificial intelligence into clinical practice.
Dr Giambrone graduated from Barts and The London School of Medicine and Dentistry in 2009 and was awarded a Distinction in her MSc from Imperial College London in 2012. She completed her specialist training in Clinical Radiology through the Royal Free London training programme before undertaking a dedicated Breast Radiology Fellowship at the Royal Free Hospital, London. Prior to relocating to the UAE, she served as a Consultant Breast Radiologist at Guy’s & St Thomas’ NHS Foundation Trust, one of the UK’s leading tertiary referral centres for breast imaging and intervention.
Since joining King’s College Hospital London – Dubai in 2023, Dr Giambrone has served as Head of Radiology while practising as a Consultant Interventional Breast Radiologist. She leads a multidisciplinary radiology department, driving strategic growth, clinical excellence and digital innovation. Under her leadership, the department has expanded its services, strengthened clinical governance, improved operational performance and reporting turnaround times, and implemented AI-enabled imaging technologies to enhance diagnostic quality and patient care.
A strong advocate for responsible innovation, Dr Giambrone has championed the adoption of artificial intelligence across multiple imaging pathways, including AI-assisted mammography, chest radiography, brain CT and ultrasound. She is passionate about translating emerging technologies into safe, effective clinical practice that enhances diagnostic accuracy, improves operational efficiency and elevates the quality of patient care.
Dr Giambrone believes the future of radiology lies at the intersection of clinical excellence, responsible artificial intelligence and compassionate, patient-centred care.
Dr. Adil Sajwani is a UAE-national Consultant Family Physician and Deputy Medical Director at Mediclinic Parkview Hospital in Dubai, with extensive experience in clinical practice, healthcare leadership, public health communication, and medical education.
Recognized as one of the top three distinguished Emirati physicians in the private sector by the Vice President of the UAE, Dr. Sajwani has delivered more than 300 lectures and webinars across government and private sectors in the UAE within the past three years, contributing significantly to public health awareness and professional education.
He is also a prominent healthcare media personality and influencer, serving as the host and presenter of “UAEBARQ,” the largest Arabic health show on social media in the UAE, reaching an audience of more than 2.5 million followers. He is a regular guest on national and international television and radio programs, where he translates complex medical topics into clear, practical, and trusted health messages for the public.
Dr. Sajwani has received several awards and recognitions for his contributions to medicine, community service, and voluntary work, including the Bahrain Award for Voluntary Work and the Sharjah Award for Voluntary Work.
He completed his medical degree at the Royal College of Surgeons in Ireland and is board-certified in Family Medicine. He also holds an Executive Master’s in Healthcare Management, a postgraduate Diploma in Public Sector Innovation from the University of Cambridge, and a postgraduate master’s-level certification in Safety, Quality, Informatics and Leadership.
In addition, Dr. Sajwani is a graduate of the UAE Government Executive Leadership Program from the Prime Minister’s Office and serves as an Advisory and Decision Committee Member at the Mohammed Bin Rashid Innovation Fund.
His work reflects a commitment to advancing healthcare leadership, empowering communities through medical knowledge, supporting innovation, and strengthening the role of Emirati physicians in shaping the future of healthcare in the UAE.
Dr. Shamsa Abdul Manan Al-Awar is an internationally recognized Emirati leader in Obstetrics and Gynecology, serving as Associate Professor and Chair of the Department of OB/GYN at the United Arab Emirates University. Board-certified in both North America and Canada (ABOG, FRCSC), she is a distinguished clinician, academic, researcher, and healthcare strategist with over two decades of impact in women’s health, medical education, and healthcare policy.
A pioneer in advancing women’s healthcare in the UAE, Dr. Al-Awar has led national initiatives in maternal health, cervical cancer prevention, medical education, and healthcare quality. She has authored numerous high-impact scientific publications, established innovative research and educational programs, and served on multiple national and regional medical and policy committees. Her exceptional contributions to medicine, leadership, and community service have earned her prestigious honors, including the Emirati Doctor Award, the UAEU Chancellor’s Medal, and the Arab Women Award in Medicine.
Dr. Dimitrios Kafetzis is the Medical Director and Founding Doctor of Almond Blossoms Fertility & Wellbeing Centre, Dubai. A Consultant in Reproductive Endocrinology, IVF, Obstetrics, and Gynecology, he brings over 16 years of international experience in fertility medicine and women’s health.
Dr. Kafetzis completed his medical degree at Democritus University of Thrace, Greece, before moving to the United Kingdom to pursue advanced specialization. He holds a Master’s Degree in Prenatal Genetics and Fetal Medicine from University College London (UCL), awarded with Distinction, and is accredited by the British Fertility Society. He trained and practiced at leading IVF centres on London’s Harley Street, including ARGC, London Women’s Clinic, and Newlife Fertility Clinic.
Prior to founding Almond Blossoms, he served as Medical Director of Orchid IVF, Dubai, from its establishment in 2016. His clinical expertise spans complex and unexplained infertility, recurrent pregnancy loss, individualized IVF and ICSI protocols, genetic testing (PGT-A, PGT-M), fertility preservation, and hormonal disorders including PCOS and endometriosis.
An internationally recognized Key Opinion Leader in reproductive medicine, Dr. Kafetzis is a regular contributor to major global fertility conferences including ESHRE, ASRM, and MEFS. He is committed to advancing personalized, evidence-based fertility care across the UAE and beyond.
Dr. Carol Coughlan is an internationally recognised Consultant in Reproductive Medicine and Surgery with over two decades of experience supporting individuals and couples through complex fertility challenges. A graduate with honours from University College Cork, she completed specialist training in Obstetrics and Gynaecology through the Royal College of Physicians of Ireland and holds Subspecialist accreditation from the Royal College of Obstetricians and Gynaecologists (UK).
She also holds a Medical Doctorate (MD) from the University of Sheffield, with doctoral research focused on recurrent miscarriage and recurrent implantation failure, areas in which she maintains a strong clinical and academic focus. Dr. Coughlan has published extensively in international peer-reviewed journals and is a frequent speaker at global fertility conferences.
Prior to relocating to the UAE in 2016, Dr. Coughlan served as Medical Director of the National Oncofertility Centre at Rotunda Hospital, Dublin, where she led one of Ireland's foremost fertility preservation programmes. She subsequently served as Medical Director at ART Fertility Clinic, Dubai. Known for her compassionate, evidence-based approach, Dr. Coughlan is dedicated to providing personalised fertility care that guides patients through every stage of their journey with confidence and clarity.
Prof. Ahmed Elbohoty is a highly skilled Consultant in Reproductive Medicine and Obstetrics & Gynecology with 23 years of experience in the field. He holds a wealth of advanced qualifications, including an MSc, MD, MRCOG, MIGSC, and EFRM, and has established himself as a leading expert in infertility management and minimally invasive endoscopic surgeries, particularly advanced hysteroscopic procedures. Currently serving as a Consultant at Trust Fertility center in Abu Dhabi, Dr. Ahmed is also a Professor of Obstetrics and Gynecology at Ain Shams University in Cairo, where he has played a pivotal role in educating and mentoring the next generation of medical professionals. Since 2009, he has held numerous consultant roles in Egypt, consistently demonstrating his clinical excellence and dedication to patient care. In addition to his clinical practice, Dr. Ahmed served as the Director of Academic Affairs for HealthPlus Network of Specialty Centers and Moorfields Eye Hospital in Abu Dhabi. He is actively involved in the Royal College of Obstetricians and Gynecologists (RCOG) and the European Society of Human Reproduction and Embryology (ESHRE), regularly participating in their initiatives and staying at the forefront of advancements in reproductive health. With a strong foundation in leadership, communication, and teamwork, Prof. Ahmed excels in both clinical and academic environments, consistently contributing to the success of the organizations he serves. His exceptional problem-solving abilities, patient-centric approach, and commitment to medical innovation make him a respected figure in the field of reproductive medicine.
Dr. Walid Sayed is an accomplished medical professional with over 30 years of experience in gynecology, obstetrics, and reproductive medicine. He holds a Bachelor of Medicine (M.B.B.S) from Ein Shams University in Egypt and specialized in gynecological endocrinology and reproductive medicine in Germany. Dr. Sayed further achieved a doctorate and German Board (Facharzt) certification in gynecology and obstetrics from Düsseldorf, Germany, making him a recognized expert in fertility and reproductive health on an international level. Throughout his career, Dr. Sayed has held key leadership positions at renowned fertility centers. He currently serves as the Group Medical Director at BMC Trust Fertility Clinic, where he oversees clinical operations and leads advanced fertility treatments. Prior to this, Dr. Sayed was the Medical Director and Consultant in Gynecology, Obstetrics, and Fertility at Healthplus Women’s Health Center in Abu Dhabi for over a decade. His extensive experience also includes notable tenures at Tawam Hospital’s IVF unit in the UAE and IVF centers across Germany, where he contributed to groundbreaking advancements in reproductive medicine. Dr. Sayed is recognized for his clinical expertise, strategic leadership, and commitment to improving patient outcomes. His contributions to fertility care, combined with his ability to guide medical teams and shape patient-centric treatment approaches, make him a highly respected figure in the field.
Dr. Vivek Mundada is a British Board-certified consultant paediatric neurologist trained in India and the UK. After completing his MBBS and DCH in India, he went to the UK for further subspeciality training. Upon completion of the subspeciality training in Paediatric Neurodisability and Neurology, he received CCT in this area.
The Royal College of Paediatrics and Child Health, UK has awarded him the MRCPCH and DCH degrees as well as the prestigious fellowship (FRCPCH). He has worked in several hospitals in the UK, including Royal London Hospital, Great Ormond Street Hospital, Addenbrookes Hospital, and Norfolk and Norwich University Hospital. His work in the field of acquired brain injury as the consultant paediatric neurologist in Royal London Hospital was acknowledged by the House of Lords, UK.
Dr. Mundada is an active member of several professional associations, including the British Paediatric Neurology Association, the European Paediatric Neurology Society, the International Child Neurology Association, the British Academy of Childhood Disability, the American Academy for Cerebral Palsy and Developmental Medicine, the International Headache Society, and the Indian Association of Paediatrics.
With his initiative, two of the Spinal Muscular Atrophy children received gene therapy for the first time in the UAE in November 2020. Till date many infants with this condition from countries like Iran, Turkey, Romania, Nepal, and Ethiopia have received successful gene therapy under his care.
Apart from the complex paediatric epilepsies and neurodevelopmental disorders, his areas of special interest lie in childhood headaches and paediatric movement disorder. He serves as a faculty for the British Paediatric Neurology Association run international courses- ‘Paediatric Epilepsy Training (PET)’ and ‘Childhood Headache Training (CHaT)’. In the areas of his interest, he has conducted and led various research projects which have been presented on various international platforms and published in peer-reviewed journals.
Dr. Vivek Mundada's training and experience makes him highly qualified to treat complex neurological conditions in children such as complex epilepsy, childhood headaches, cerebral palsy and other movement disorders, neurodevelopmental disorders, neonatal neurology, neuromuscular disorders, complex neurodisability and congenital neurological disorders.
In addition to his work as a medical specialist, Dr. Mundada loves to sing and is formally trained in Indian classical music. He has been actively involved in teaching students and nurses at different hospitals and medical colleges in UK and India. He loves reading literature and traveling. Dr. Mundada speaks English, Hindi, Marathi and Urdu.
Sally is a senior presenter and keynote speaker who has interviewed many of the world’s most influential change-makers across every field over the last two decades. She regularly speaks on transformation, leadership, communication, women's empowerment, and intercultural dialogue. From Prince Khaled bin Alwaleed bin Talal to Nobel Laureates like Kailash Satyarthi, Hollywood superstars like Steve Harvey, Olympic medallists like Ibtihaj Muhammad, visionaries like Dr Jane Goodall, top coaches and authors like Robin Sharma and Jay Shetty, amongst many others, Sally has a gift for telling the stories of those who have made a global impact, revealing deeper insights that others miss. As an Arab-Australian, Sally is passionate about powerful stories that explore diverse narratives and are part of conversations driving change worldwide.
Ramia is a Senior Presenter and Producer at Forbes Middle East where she delivers business news updates and lead interviews and podcasts with influential business leaders, policymakers, and innovators shaping the Middle East and beyond. For over two decades she’s specialized in presenting business and current affairs across international platforms. Previously she presented Emirates News on Dubai One TV for 15 years, where she also served as News Bulletin Editor. Earlier in her career, she produced and presented Business Arabia on CNBC World, delivering Middle East economic coverage to a global audience. Ramia’s work has included interviews with world leaders including General Pervez Musharraf, President of Pakistan, Mohammed Khatami, President of Iran, Gerhard Schroeder, Chancellor of Germany and Jimmy Carter, US President. She’s also a moderator at major public and private sector forums, guiding strategic conversations on topics ranging from AI and sustainability to finance and diplomacy. She’s a contributor to several publications, with a focus on economic transformation, leadership, and innovation. Ramia holds a MA in Global Diplomacy-International Relations from the University of London, SOAS, a BA in Communications from the University of Winnipeg and an Associate’s Degree in Journalism from Red River College.
Budour Al Mousa is a Senior Presenter and Producer at Forbes Middle East, where she covers business, economics, investment, technology, and leadership across the Middle East.
She has conducted interviews with ministers, policymakers, CEOs, entrepreneurs, and senior executives from some of the region’s leading organizations, delivering in-depth conversations on the trends shaping the future of business and economic development.
Alongside her work in media, Al Mousa lectures in Public Speaking and Presentation Skills at Moscow State University. Her expertise spans broadcast journalism, executive interviews, event moderation, and strategic business storytelling, making her a trusted voice in conversations at the intersection of business, policy, and innovation.
Jayda is a content producer at Forbes Middle East; her experience ranges from writing and editing to video production across radio and television. As a member of the multimedia team, Jayda has conducted many interviews with experts in various fields and frequently covers macroeconomic, tech, and energy news. Jayda holds a Bachelor’s degree in Mass Communication and Journalism from Monash University and is currently pursuing her Masters in TV & Digital Journalism at the American University in Cairo.
As the Women Editor and Researcher at Forbes Middle East, Layan oversees a few lists and rankings and helps in creating the rest. She also writes for the cover of the printed monthly magazine of Forbes Middle East and hosts and produces The Under 30 Chit-Chat, a podcast dedicated to highlighting our 30 Under 30 listers who are shaping the future of the region. Layan holds a bachelor’s degree in journalism from The American University of Sharjah and has interviewed top decision-makers and some of the most important business leaders of the MENA region for print and video. She has also moderated and hosted several events across the region.
A forward-thinking conversation on how evolving regulatory frameworks are enabling innovation in areas such as AI, genomics, and digital care while maintaining safety, accountability, and public confidence
This session will highlight how regulatory evolution and industry readiness are enabling faster access to innovative medicines and reinforcing the UAE’s role as a regional hub for pharmaceutical advancement.
Examine how public–private collaborations have been pivotal in strengthening healthcare capacity, expanding specialised services, and supporting national health priorities.
Explore how longevity science, advanced health insights, and personalised interventions are enabling individuals to live longer, healthier, and more fulfilling lives.
Examine how genomics and advanced diagnostic capabilities are enabling more precise clinical decisions and reshaping treatment pathways across complex and chronic conditions.
Delve into how advanced analytics, intelligent screening, and integrated health data are enabling earlier intervention and reshaping predictive and proactive health models.
A discussion centred on how coordinated and integrated healthcare networks are enabling more effective long-term management of chronic and non-communicable diseases.
With insurance emerging as a key enabler of access, care navigation, and cross-border treatment, gain leadership perspectives on its evolving role in modern healthcare delivery.
Gain expert insights on how mental health is being advanced as a core population health priority through expanded access and greater integration across care environments.
As AI, robotics, and advanced data become embedded within clinical environments, understand from visionary leaders how these technologies are enhancing decision-making, automation, and operational precision.
With wearable technologies and digital platforms enabling continuous health engagement, gain expert insights on how these innovations are strengthening real-time engagement and more connected patient experiences.
As healthcare delivery expands beyond traditional facilities, delve into futuristic perspectives on how virtual platforms, remote monitoring, and hybrid models are reengineering access and delivery.
An in-depth discussion on how emerging discoveries are progressing beyond the research phase into clinical application, enabling new therapies and advancing real-world patient outcomes.
Explore how global trials, cross-border partnerships, and international collaboration are strengthening the UAE’s role in advancing medical progress and therapeutic development.
Understand from experts how biologics, cell and gene therapies, and advanced treatment modalities are revolutionising therapeutic possibilities for complex and previously untreatable conditions.
Examine how investment and private sector leadership are enabling scalable healthcare platforms, strengthening infrastructure, and driving long-term sector growth and sustainability.
Delve into how venture capital and startups are enabling breakthrough technologies, accelerating commercialisation, and strengthening the pipeline of scalable healthcare solutions.
A deep thought conversation on how healthcare systems are evolving to deliver greater value, efficiency, and long-term sustainability amid rising demand and cost pressures.
Limited seating is available, Register now to secure your spot and be part of this
unique experience. Please proceed to select the Visitor Pass and click “Next.” If you wish to purchase multiple
tickets, please choose the “Group Member” option on the next page before submitting.
Emirates Palace is an iconic luxury hotel that epitomizes Arabian grandeur and has often been described as a “palace rather than just a hotel”. the hotel’s aesthetic merges Islamic architectural elements such as harmonious geometry and rhythmic proportions—with modern construction techniques.

Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.